Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Pyrexia, Skin exfoliation
Clinical narrative: my fever was high; excruciating body pain; my face peeled from my jawbone on both sides all the way up to the top of my hairline with mild itching; my face peeled from my jawbone on both sides all the way up to the top of my hairline with mild itching; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18May2022 at 14:30 as dose 4 (booster), single (Lot number: Fj4989) at the age of 56 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "atrial Fibrillation" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; HCTZ; DILTIAZEM; ELIQUIS. Past drug history included: Levaquin, reaction(s): "known allergies"; Regina, reaction(s): "known allergies"; Codeine, reaction(s): "known allergies"; Morphine, reaction(s): "known allergies". Vaccination history included: BNT162b2 (Prev dose product: COVID 19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose lot unknown: True, Prev dose lot unknown reason: Not available/provided to reporter at the time of report completion., Prev dose administration date: 10Oct2021, Prev dose dose number: 3, Prev dose vaccine location: Left arm, Dose number three of Pfizer left me with mild symptoms.), administration date: 10Oct2021, when the patient was 56-year-old, for COVID-19 immunization, reaction(s): "Dose number three of Pfizer left me with mild symptoms."; BNT162b2 (Prev dose product: COVID 19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose lot number: Ew0150, Prev dose lot unknown: False, Prev dose administration date: 11Apr2021, Prev dose dose number: 2, Prev dose vaccine location: Left arm), administration date: 11Apr2021, when the patient was 55-year-old, for COVID-19 immunization; BNT162b2 (Prev dose product: COVID 19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose lot number: Ep6955, Prev dose lot unknown: False, Prev dose administration date: 19Mar2020, Prev dose dose number: 1, Prev dose vaccine location: Left arm), administration date: 19Mar2020, when the patient was 54-year-old, for COVID-19 immunization.  The following information was reported: PAIN (non-serious) with onset 19May2022 at 16:30, outcome "recovering", described as "excruciating body pain"; SKIN EXFOLIATION (non-serious), PRURITUS (non-serious) all with onset 19May2022 at 16:30, outcome "recovering" and all described as "my face peeled from my jawbone on both sides all the way up to the top of my hairline with mild itching"; PYREXIA (non-serious) with onset 19May2022 at 16:30, outcome "recovering", described as "my fever was high". Therapeutic measures were not taken as a result of pyrexia, pain, skin exfoliation, pruritus.  Clinical significance: Adverse event: The adversary action is for the most recent dose number four or the second booster of Pfizer. Dose number three of Pfizer left me with mild symptoms. This dose my fever was high, excruciating body pain, and my face peeled from my jawbone on both sides all the way up to the top of my hairline with mild itching. No treatment received for the event. No covid vaccination prior vaccination, no covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.  Follow-Up (25May2022): Follow-up attempts are completed. No further information is expected.